Urticaria

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 58, Issue 12, 2003, Pages 1224-1234

  Zuberbier, T ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Definition; Pathogenesis; Therapy; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; COUMARIN; CYCLOSPORIN A; DANAZOL; DAPSONE; DOXEPIN; DOXYCYCLINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN; INTERFERON; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NIFEDIPINE; PENICILLIN G; PENTOXIFYLLINE; PREDNISOLONE; SULFAMETHOXYPYRIDAZINE;

ACUTE DISEASE; CARDIOVASCULAR DISEASE; CHRONIC URTICARIA; CLINICAL FEATURE; CLINICAL TRIAL; COLD URTICARIA; CONTACT URTICARIA; CRYOTHERAPY; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG TOLERABILITY; HISTOLOGY; HUMAN; PATHOGENESIS; PHYSICAL TOLERANCE; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; QUALITY OF LIFE; REVIEW; SEDATION; SIDE EFFECT; SOLAR URTICARIA; URTICARIA; URTICARIA PIGMENTOSA;

HUMANS; URTICARIA;

EID: 0344825328     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1398-9995.2003.00327.x     Document Type: Review

References (94)

1. POON E, SEED PT, GREAVES MW, KOBZA-BLACK A. The extent and nature of disability in different urticarial conditions. Br J Dermatol 1999;140:667-671.
2. KONTOU-FILI K, BORICI-MAZI R, KAPP A, MATJEVIC LJ, MITCHEL FB. Physical urticaria: classification and diagnostic guidelines. An EAACI position paper. Allergy 1997;52:504-513.
3. GRATTAN C, POWELL S, HUMPHREYS F. Management and diagnostic guidelines for urticaria and angioedema. Br J Dermatol 2001;144:708-714.
4. ZUBERBIER T, GREAVES MW, JUHLIN L, KOBZA-BLACK A, MAURER D, STINGL G et al. Definition, classification and routine diagnosis of urticaria - a consensus report. J Invest Dermatol Symp Proc 2001;6:123-127.
5. ZUBERBIER T, GREAVES MW, JUHLIN L, MERK H, STINGL G, HENZ BM. Management of urticaria - a consensus report. J Invest Dermatol Symp Proc 2001;6:128-131.
6. HAAS N, SCHADENDORF D, HENZ BM. Endothelial adhesion molecules in immediate and delayed urticarial whealing reactions. Int Arch Allergy Immunol 1998;115:210-214.
7. BARLOW RJ, ROSS EL, MACDONALD D, KOBZA BLACK A, GREAVES MW. Adhesion molecule expression and the inflammatory cell infiltrate in delayed pressure urticaria. Br J Dermatol 1994;131:341-347.
8. ZUBERBIER T, SCHADENDORF D, HAAS N, HARTMANN K, HENZ BM. Enhanced P-selectin expression in chronic and dermographic urticaria. Int Arch Allergy Clin Immunol 1997;114:86-89.
9. HERMES B, PROCHAZKA AK, HAAS N, JURGOVSKY K, STICHERLING M, HENZ BM. Upregulation of tumor necrosis α and interleukin-3 expression in lesional and uninvolved skin in different types of urticaria. J Allergy Clin Immunol 1999;103:307-314.
10. SHELDON JM, MATHEWS KP, LOVELL RG. The vexing urticaria problem. Present concepts of etiology and management. J Allergy 1954;25:525-560.
11. CHAMPION RH, ROBERTS SOB, CARPENTER RG, ROGER JH. Urticaria and angioedema: a review of 554 patients. Br J Dermatol 1969;81:588-597.
12. SWINNY B. The atopic factor in urticaria. South Med J 1941;34:855-858.
13. IFFLÄNDER J. Akute Urtikaria - Ursachen, Verlauf und Therapie. Diss. (Med. Doct.) Berlin: Humboldt University, 1999.
14. ZUBERBIER T, IFFLÄNDER J, SEMMLER C, CZARNETZKI BM. Acute urticaria - clinical aspects and therapeutical responsiveness. Acta Derm Venereol (Stockh) 1996;76:295-297.
15. SIMONS FER. Prevention of acute urticaria in young children with atopic dermatitis. J Allergy Clin Immunol 2001;107:703-706.
16. LEGRAIN V, TAIEB A, SAGE T, MALEVILLE J. Urticaria in infants: a study in 40 patients. Pediatr Dermatol 1990;7:101-107.
17. KAUPPINEN K, JUNTUNEN K, LANKI H. Urticaria in children. Retrospective evaluation and follow-up. Allergy 1984;39:469-472.
18. AOKI T, KOJIMA M, HORIKO T. Acute urticaria: history and natural course of 50 patients. J Dermatol 1994;21: 73-77.
19. JUHLIN L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol 1981;104:369-381.
20. ZUBERBIER T, CHANTRAINE-HESS S, HARTMANN K, CZARNETZKI BM. Pseudoallergen-free diet in the treatment of chronic urticaria - a prospective study. Acta Derm Venereol (Stockh) 1995;75:484-487.
21. PIGATTO PD, VALSECCHI RH. Chronic urticaria: a mystery. Allergy 2000;55:306-308.
22. ZUBERBIER T, PFROMMER C, SPECHT K, VIETHS S, BASTL-BORRMANN R, WORM M et al. Aromatic components of food as novel eliciting factors of pseudoallergic reactions in chronic urticaria. J Allergy Clin Immunol 2002;109: 348-349.
23. HIDE M, FRANCIS DM, GRATTAN CEH, HAKIMI J, KOCHAN JP, GREAVES MW. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-1604.
24. FIEBIGER E, HAMMERSCHMID F, STINGL G, MAURER D. Anti-FcεRI-α autoantibodies in autoimmune-mediated disorders. Identification of a structure-function relationship. J Clin Invest 1998;101:243-251.
25. KIKUCHI Y, KAPLAN AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol 2001;107:1056-1062.
26. ZUBERBIER T, FIEBIGER E, MAURER D, STINGL G, HENZ BM. Anti-FcεRIα serum autoantibodies in different subtypes of urticaria. Allergy 2000;55: 951-954.
27. STADLER BM, PACHLOPNIK J, VOGEL M, HORN M, DAHINDEN M, MIESCHER S. Conditional autoantibodies in urticaria patients: a unifying hypothesis. J Invest Dermatol Symp Proc 2001;6:150-152.
28. HORN MP, PACHLOPNIK JM, VOGEL M, DAHINDEN M, WURM F, STADLER BM et al. Conditional autoimmunity mediated by human natural anti-Fc(epsilon)RIalpha autoantibodies? FASEB J 2001;15:2268-2274.
29. LEZNOFF A, SUSSMAN GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989;84:66-71.
30. WEDI B, KAPP A. Helicobacter pylori infection and skin diseases. J Physiol Pharmacol 1999;50:753-776.
31. GAIG P, GARCIA-URTEGA P, ENRIQUE E, PAPO M, QUER JC, RICHARD C. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria. A placebo-controlled double blind study. Allergol Immunopathol (Madr) 2002;30:255-258.
32. SCHNYDER B, HELBING A, PICHLER WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999;119: 60-63.
33. WEDI B, KAPP A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002;3:273-282.
34. BRUNO G, ANDREOZZI P, GRAF U. Exercise-induced urticaria-angioedema syndrome: a role in gastroesophageal reflux. In: VENA GA, PUDDU P, editors. Proceedings of the International Symposium on Urticaria. Bari: Publ. Scientif., 1998:85-89.
35. HENZ BM, JEEP S, ZIEGERT FS, NIEMANN J, KUNKEL G. Dermal and bronchial hyperreactivity in urticarial dermographism. Allergy 1996;51: 171-175.
36. MÖLLER A, HENNING M, ZUBERBIER T, CZARNETZKI BM. Epidemiologie und Klinik der Kälteurtikaria. Hautarzt 1996;47:510-514.
37. DUKE WW. Physical allergy as a cause of dermatoses. Arch Derm Syph 1926;13:176-186.
38. LEENUTAPHONG V, HOLZLE E, PLEWIG G. Pathogenesis and classification of solar urticaria: a new concept. J Am Acad Dermatol 1989;21: 237-240.
39. BEISSERT S, STANDER H, SCHWARZ T. UVA rush hardening for the treatment of solar urticaria. J Am Acad Dermatol 2000;42:1030-1032.
40. LAWLOR F, BLACK AK, BREATHNACH AS, GREAVES MW. Vibratory angioedema: lesion induction, clinical features, laboratory and ultrastructural findings and response to therapy. Br J Dermatol 1989;120:93-99.
41. SHELLEY WB, SHELLEY ED. Adrenergic urticaria: a new form of stress-induced hives. Lancet 1985;2:1031-1033.
42. WÜTHRICH B. Adverse reactions to food additives. Ann Allergy 1993;71:379-384.
43. GRATTAN CEH, FRANCIS DM, SLATER NGP, BARLOW RJ, GREAVES MW. Plasmapheresis for severe unremitting chronic urticaria. Lancet 1992;339:1078-1080.
44. GREAVES M. Chronic urticaria. J Allergy Clin Immunol 2000;105: 664-672.
45. GRATTAN CEH, O'DONNELL BFO, FRANCIS DM, NIIMI N, BARLOW RJ, SEED PT et al. Randomized double-blind study of cyclosporin in chronic 'idiopathic' urticaria. Br J Dermatol 2000;143:365-372.
46. BARLOW RJ, BLACK AK, GREAVES MW. Treatment of severe chronic urticaria with cyclosporin A. Eur J Dermatol 1993;3:273-275.
47. FRADIN MS, ELLIS CN, GOLDFARB MT, VOORHEES JJ. Oral cyclosporin for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol 1991;25:1065-1067.
48. TOUBI E, BLANT A, KESSEL A, GOLAN TD. Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria. Allergy 1997;52:312-316.
49. O'DONNELL BF, BARR RM, BLACK AK, FRANCIS DM, KERMANI F, NIIMI N et al. Intravenous immunoglobulin in autoimmune chronic urticaria. Br J Dermatol 1998;138:101-106.
50. PFROMMER C, BASTL R, VIETHS S, EHLERS I, HENZ BM, ZUBERBIER T. Characterization of naturally occurring pseudoallergens causing chronic urticaria. J Allergy Clin Immunol 1996; 97:367.
51. STELLATO C, DE PAULIS A, CICCARELLI A, CIRILLO R, PATELLA V, CASOLARO V et al. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J Invest Dermatol 1992;98:800-804.
52. GODT O, PROKSCH E, STREIT V, CHRISTOPHERS E. Short-and long-term effectiveness of oral and bath PUVA therapy in urticaria pigmentosa and systemic mastocytosis. Dermatology 1997;195:35-39.
53. HORIO T. Indications and action mechanisms of phototherapy. J Dermatol Sci 2000;23(Suppl 1):S17-S21.
54. HANNUKSELA M, KOKKONEN EL. Ultraviolet light therapy in chronic urticaria. Acta Derm Venereol 1985;65:449-450.
55. OLAFSSON JH, LARKO O, ROUPE G, GRANERUS G, BENGTSSON U. Treatment of chronic urticaria with PUVA or UVA plus placebo: a double-blind study. Acta Dermatol Res 1986;278:228-231.
56. 1-antagonist descarboethoxy-loratadine and dexamethasone from human mast and basophilic cell lines. Exp Dermatol 1995;4:272-276.
57. 2-receptor antagonists. Exp Dermatol 2000;9:118-124.
58. KONTOU-FILI K, MANIAKATOU G, DEMAKA P, PALEOLOGOS G. Therapeutic effect of cetirizine 2HCl in delayed pressure urticaria. Health Sci Rev 1989;3:23-25.
59. ZUBERBIER T, MÜNZBERGER Ch, HAUSTEIN U, TRIPPAS E, MARIZ SD, CZARNETZKI BM. Double-blind cross-over study of high dose cetirizine in cholinergic urticaria. Dermatology 1996;193:324-327.
60. KAPLAN AP. Clinical practice. Chronic urticaria and angioedema. N Engl J Med 2002;346:175-179.
61. WARIN RP, SMITH RJ. Challenge test battery in chronic urticaria. Br J Dermatol 1976;94:401-405.
62. GENTON C, FREI PC, PÉCOUD A. Value of oral provocation tests to aspirin and food additives in routine investigation of asthma and chronic urticaria. J Allergy Clin Immunol 1985;76: 40-45.
63. MICHAELSSON G, JUHLIN L. Urticaria induced by preservatives and dye additives in food and drugs. Br J Dermatol 1973;88:525-532.
64. THUNE P, GRANHOLT A. Provocation tests with antiphlogistica and food additives in recurrent urticaria. Dermatologica 1975;151:360-367.
65. WÜTHRICH B, FABRO L. Acetylsalicylsäure-und Lebensmitteladditiva-Intoleranz bei Urtikaria, Asthma bronchiale und chronischer Rhinopathie. Schweiz Med Wschr 1981;111:1445-1450.
66. ORTOLANI C, PASTORELLO E, LURAGHI MT, DELLA TORRE F, BELLANI M, ZANUSSI C. Diagnosis of intolerance to food additives. Ann Allergy 1984;53:587-591.
67. RUDZKI E, CZUBALSKI K, GRZYWA Z. Detection of urticaria with food additives intolerance by means of diet. Dermatologica 1980;161:57-62.
68. ROS AM, JUHLIN L, MICHAELSSON G. A follow-up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes. Br J Dermatol 1976;95:19-24.
69. VERSCHAVE A, STEVENS E, DEGREEF H. Pseudo-allergen-free diet in chronic urticaria. Dermatologica 1983;167:256-259.
70. GIBSON A, CLANCY R. Management of chronic idiopathic urticaria by the identification and exclusion of dietary factors. Clin Allergy 1980;10:699-704.
71. KIRCHHOF B, HAUSTEIN UF, RYTTER M. Azetylsalizylsäure-Additiva- Intoleranzphänomene bei chronisch rezidivierender Urtikaria. Dermatol Monatsschr 1982;168:513-519.
72. SUPRAMANIAM G, WARNER JO. Artificial food additive intolerance in patients with angio-oedema and urticaria. Lancet 1986;II:907-909.
73. BROSTOFF J, FITZHARRIS P, DUNMORE C, THERON M, BLONDIN P. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Allergy 1996;51:320-325.
74. FROSSARD N, BENABDESSELAM O, PUROHIT A, MOUNEDJI N, PAULI G. Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steady state treatment in the skin of healthy volunteers. Fund Clin Pharmacol 2000;14:409-413.
75. MONROE EW, BERNSTEIN DI, FOX RW, et al. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Arzneimittelforschung 1992;42:1119-1121.
76. NELSON HS, REYNOLDS R, MASON J. Fexofenadine HCl is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol 2000;84:517-522.
77. RING J, HEIN R, GAUGER A, BRONSKY E, MILLER B. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Int J Dermatol 2001;40:72-76.
78. ZUBERBIER T, HENZ BM. Use of cetirizine in dermatologic disorders. Ann Allergy Asthma Immunol 1999;83: 476-480.
79. PARSAD D, PANHI R, JUNEJA A. Stanozolol in chronic urticaria: a double blind placebo controlled trial. J Dermatol 2001;28:299-302.
80. HENZ BM, ZUBERBIER T, MONROE E. Urticaria therapy. In: HENZ BM, ZUBERBIER T, GRABBE J, MONROE E, editors. Urticaria. Clinical, diagnostic and therapeutic aspects. Berlin: Springer. 1998:161-181.
81. SOTER NA. Urticaria: current therapy. J Allergy Clin Immunol 1990;86: 1009-1014.
82. BRESSLER RB, SOWELL K, HUSTON DP. Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial. J Allergy Clin Immunol 1989;83: 756-763.
83. BRESTEL EP. Danazol in chronic urticaria. J Allergy Clin Immunol 1990;85:1112.
84. ELLIS MH. Successful treatment of chronic urticaria with leukotriene antagonists. J Allergy Clin Immunol 1989;102:876-877.
85. PACOR ML, DI LORENZO G, CORROCHER R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001;31:1607-1614.
86. HARTMANN K, HANI N, HINRICHS R, HUNZELMANN N, SCHARFETTER-KOCHANEK K. Successful sulfasalazine treatment of severe chronic idiopathic urticaria associated with pressure urticaria. Acta Derm Venerol 2001;81:71.
87. CZARNETZKI BM, ALGERMISSEN B, JEEP S, HAAS N, NÜRNBERG W, MÜLLER K et al. Interferon treatment of patients with chronic urticaria and mastocytosis. J Am Acad Dermatol 1994;30: 500-501.
88. PARSLEW R, PRYCE D, ASHWORTH J, FRIEDMANN PS. Warfarin treatment of chronic idiopathic urticaria and angio-oedema. Clin Exp Allergy 2000;30:1161-1165.
89. SHARPE GR, SHUSTER S. The effect of cetirizine on symptoms and whealing in dermographic urticaria. Br J Dermatol 1993;129:580-583.
90. BERKUN Y, SHALIT M. Successful treatment of delayed pressure urticaria with montekulast. Allergy 2000;55:203-204.
91. NEITTAANMAKI H, FRAKI JE, GIBSON JR. Comparison of the new antihistamine acrivastine (BW 825C) versus cyproheptadine in the treatment of chronic idiopathic urticaria. Dermatologica 1988;177:98-103, 1988.
92. CLAUDY, A. Cold urticaria. J Invest Dermatol Symp Proc 2001;6:141-142.
93. HANI N, HARTMANN K, CASPER C, PETERS T, SCHNEIDER LA, HUNZELMANN N et al. Improvement of cold urticaria by treatment with the leukotriene receptor antagonist montekulast. Acta Derm Venereol 2000;80:229.
94. BILSLAND D, FERGUSON J. A comparison of cetirizine and terfenadine in the management of solar urticaria. Photodermatol Photoimmunol Photomed 1991;8:62-64.